Major Scope

  •  Lung Cancer
  •  Colorectal Cancer
  •  Pancreatic Cancer
  •  Breast Cancer
  •  Prostate Cancer
  •  Liver Cancer
  •  Leukemia
  •  Bladder Cancer
  •  Kidney Cancer
  •  Endometrial Cancer
  •  Oncology Case Reports
  •  Radiation Therapy

Abstract

Citation: Clin Oncol. 2024;9(1):2096.DOI: 10.25107/2474-1663-v9-id2096

Correlation of Neutrophil/Lymphocyte Levels with Cognitive Dysfunction Impairment in Mild and Medium- Sized Traumatic Brain Injury

Xinyi Z and Lumao H

Zheng Xinyi Unit, Chaohu Hospital Affiliated to Anhui Medical University, China

*Correspondance to: Huang Lumao 

 PDF  Full Text Research Article | Open Access

Abstract:

Background: To explore the correlation between Neutrophil/Lymphocyte (NLR) levels and mild and medium-sized traumatic brain injury and cognitive impairment, to provide early diagnosis and intervention of possible traumatic brain injury and cognitive impairment in high levels of NLR. Methods: Selected from September 2022 to September 2023 in Chaohu Hospital affiliated to Anhui Medical University neurosurgery of traumatic brain injury light and medium cognitive dysfunction each 100 cases, and the same period to the health center of 100 cases, all the enrolled object are complete general data collection, biochemical and NLR detection, MoCA scale score, head CT examination. TBI is diagnosed according to a clinician outside the professional god. Results: NLR, WBC and TBIL were significant. Moreover, the combination of leukocytes and NLR can significantly improve the predictivity of TBI in cognitive dysfunction. Conclusion: We conclude that the serum inflammatory markers of TBI NLR, WBC and the antioxidant straight bilirubin are predictive of cognitive dysfunction in TBI.

Keywords:

Neutrophils/Lymphocytes; Inflammation; Antioxidants; Traumatic brain injury; Cognitive dysfunction

Cite the Article:

Xinyi Z, Lumao H. Correlation of Neutrophil/Lymphocyte Levels with Cognitive Dysfunction Impairment in Mild and Medium-Sized Traumatic Brain Injury. Clin Oncol. 2024;9:2096..

Journal Basic Info

  • Impact Factor: 3.231**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
  • PubMed NLM ID: 101705590

Search Our Journal

Journal Indexed In

Articles in PubMed

NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Systematic Review and Meta-Analysis of PD-1 and CTLA-4 Bispecific Antibody in the Treatment of Gastric Cancer
 Abstract  PDF  Full Text
Regional Recurrence of Breast Cancer in Ipsilateral Intramammary Lymph Node Six Months after Breast Conserving Surgery
 Abstract  PDF  Full Text
View More...